Farms.com Home   Ag Industry News

New Purple Wheat Variety Seizes Fiber Intake Trend

New Purple Wheat Variety Seizes Fiber Intake Trend
Mar 24, 2026
By Farms.com

New OSU wheat variety offers health benefits and niche market potential

A new winter wheat variety developed by Oklahoma State University is gaining attention for its unique health and market benefits. Known as OSU-P92, this wheat contains anthocyanins; natural pigments that are also found in foods like blueberries and pomegranates. These compounds are known for supporting gut and brain health. 

"This is new -- so new that I only know of a few wheat breeding programs in North America that are commercializing pigmented bran varieties," said Dr. Brett Carver, Regent's professor and wheat genetics chair in the OSU Department of Plant and Soil Sciences. "We were after qualities that are just not normally present in winter wheat." 

Unlike traditional wheat, OSU-P92 combines strong disease resistance, good baking quality, and added nutritional value. It also supports efforts to increase fiber intake, as whole wheat products contain significantly more fiber than refined flour. Researchers believe this variety may help more people to choose whole grain foods. 

The wheat was developed by combining multiple varieties to achieve a balance of yield, adaptability, and health traits. It shows higher levels of anthocyanins compared to conventional wheat and maintains consistent quality across different growing conditions. 

"We specialize in finding specialty, niche markets where we provide high-value, high-quality products, such as purple wheat, that require special handling," said Brady Sidwell, a wheat producer and business owner in Enid, Oklahoma.  

"It's not only delivering the pure, wholesome product that consumers want; it's also giving agriculture a voice by connecting growers directly to consumers. We can create an identity-preserved product that is truly local. I see it as a form of rural development," said Sidwell. 

Farmers are also seeing potential benefits. Specialty wheat like OSU-P92 can open doors to niche markets that offer higher prices. However, growing this wheat requires careful handling to maintain purity, which may involve additional equipment and investment. 

From a processing perspective, the wheat performs well in stone milling, where the entire grain is used. This method preserves flavor, color, and nutritional value. Bakers report that the flour produces unique textures and flavors, making it suitable for artisan bread products. 

Demand for this wheat is growing among millers and bakers who are interested in high-quality, locally sourced ingredients. Consumers are also showing interest in products that combine health benefits with good taste. 

Overall, OSU-P92 represents a step forward in wheat innovation. It connects farmers more closely with consumers while offering a product that meets modern preferences for nutrition, flavor, and sustainability. 

Photo Credit: Oklahoma State University 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.